Reactions Weekly

November 2019, Volume 1781, Issue 1, pp 1–1 | Cite as

Interstitial lung disease risk with prostate cancer meds

News item

First Online: 30 November 2019

• 56 Downloads

This is a preview of subscription content, log in to check access.

References

1. 1.
   Pharmaceuticals and Medical Devices Agency of Japan. Summary of Investigation Results - Apalutamide. Internet Document : [2 pages], 15 Nov 2019. Available from: URL: http://www.pmda.go.jp/files/000232288.pdf
2. 2.
   Pharmaceuticals and Medical Devices Agency of Japan. Summary of Investigation Results - Enzalutamide. Internet Document : [2 pages], 15 Nov 2019. Available from: URL: http://www.pmda.go.jp/files/000232289.pdf

Copyright information

© Springer International Publishing AG 2019